Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Curevac N.V. | CVAC | 10. jui 2024 | 4.59 | +2.23 |
CuriosityStream | CURI | 10. jui 2024 | 0.98 | -2.97 |
Curis | CRIS | 10. jui 2024 | 8.00 | -9.50 |
Curtiss-Wright | CW | 10. jui 2024 | 272.61 | +0.39 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | 10. jui 2024 | 43.15 | +1.55 |
Cushman & Wakefield | CWK | 10. jui 2024 | 10.28 | +0.10 |
Custom Truck One Source | CTOS | 10. jui 2024 | 4.69 | +0.21 |
Customers Bancorp | CUBI | 10. jui 2024 | 43.17 | -0.67 |
Customers Bancorp E Pref | CUBI-E | 10. jui 2024 | 25.35 | +0.12 |
Customers Bancorp F Pref | CUBI-F | 10. jui 2024 | 25.21 | -0.02 |
Cutera | CUTR | 10. jui 2024 | 1.98 | +3.13 |
CVB Financial | CVBF | 10. jui 2024 | 16.29 | -1.03 |
CVD Equipment | CVV | 10. jui 2024 | 4.31 | -1.00 |
CVR Energy | CVI | 10. jui 2024 | 27.05 | +0.26 |
Cvr Partners LP Unit | UAN | 10. jui 2024 | 79.62 | -0.85 |
CVRx | CVRX | 10. jui 2024 | 9.13 | -5.19 |
CVS Health | CVS | 10. jui 2024 | 60.28 | -2.43 |
CXApp A | CXAI | 10. jui 2024 | 2.51 | -4.20 |
CyberArk Software | CYBR | 10. jui 2024 | 252.46 | +5.20 |
Cybin | CYBN | 10. jui 2024 | 0.28 | -2.04 |
Cyclacel Pharmaceuticals | CYCC | 10. jui 2024 | 1.88 | -6.00 |
Cyclacel Pharmaceuticals Pref | CYCCP | 10. jui 2024 | 7.70 | 0.00 |
Cyclerion Therapeutics | CYCN | 10. jui 2024 | 2.27 | -11.11 |
Cyclo Therapeutics | CYTH | 10. jui 2024 | 1.25 | -0.79 |
Cyngn | CYN | 10. jui 2024 | 0.10 | +11.57 |
Cytek Biosciences | CTKB | 10. jui 2024 | 6.01 | +0.17 |
Cytokinetics | CYTK | 10. jui 2024 | 54.16 | +2.60 |
Cytomed Therapeutics | GDTC | 10. jui 2024 | 2.00 | +2.55 |
CytomX Therapeutics | CTMX | 10. jui 2024 | 1.63 | -0.61 |
Cytosorbents | CTSO | 10. jui 2024 | 0.89 | +0.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.